Glow (GHK-Cu / TB-500 / BPC-157)

Glow is a multi-component research blend combining three synthetic peptides — GHK-Cu (a copper-binding tripeptide), TB-500 (a synthetic fragment derived from the thymosin beta-4 sequence), and BPC-157 (a stable gastric pentadecapeptide-derived sequence) — formulated together for laboratory and professional research applications within the Healing & Recovery catalog category. Each constituent has an independent body of preclinical literature, and this combination is of interest to investigators examining tissue-, matrix-, and skin-related research models. This material is supplied strictly for research and professional use and is not approved by the FDA for therapeutic use. It is intended for qualified, licensed practitioners and laboratory settings only.

The three peptides are frequently grouped in research discussion because their individually studied pathways — extracellular matrix remodeling, actin and cell-migration dynamics, and cytoprotective signaling — are conceptually adjacent areas of investigation. As with all early-stage research compounds, characterization is ongoing and findings in the published literature are preliminary; individual results vary.

• Investigated in preclinical literature for skin- and dermal-related research models, including studies referencing extracellular matrix and collagen-associated pathways (GHK-Cu)
• Studied in research settings using soft-tissue, tendon, and ligament repair-process models (BPC-157, TB-500)
• Reported in research to be of interest for cell migration and angiogenesis-related investigation (TB-500, BPC-157)
• Examined in laboratory models exploring tissue-remodeling and recovery-associated signaling
• Referenced in research literature on copper-peptide chemistry and antioxidant-pathway investigation (GHK-Cu)

Reference handling for laboratory use: lyophilized material is typically reconstituted with bacteriostatic water (or sterile water for research purposes) added gently against the vial wall, then swirled rather than shaken until dissolved. Store unreconstituted vials sealed, cool, and protected from light; many research peptides are kept refrigerated, with longer-term storage of lyophilized powder often at or below freezing per supplier specifications. After reconstitution, keep refrigerated, protect from light and repeated temperature cycling, and use within a limited working window consistent with peptide stability. Avoid prolonged exposure to heat, light, and air. Use aseptic technique and appropriate personal protective equipment when handling. This is reconstitution, storage, and handling reference information only; all clinical and research protocols, including any decisions regarding use, are determined solely by the licensed ordering provider, and this material is provided for research and professional use and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published preclinical literature, each component is associated with a distinct proposed mechanism. GHK-Cu is studied as a copper-binding tripeptide reported to interact with extracellular matrix components and to be of research interest in collagen- and remodeling-associated signaling. TB-500, a synthetic peptide related to the thymosin beta-4 sequence, is investigated for its proposed role in actin regulation, cell migration, and angiogenesis in research models. BPC-157 is examined for proposed cytoprotective and angiogenic signaling activity, with research interest in growth-factor and nitric-oxide-pathway interactions. The combined mechanistic rationale for studying these peptides together is hypothetical and based on overlapping research pathways rather than established clinical mechanisms; these descriptions are research-framed, not statements of efficacy, and individual results vary.